6512-31-8 Usage
Uses
Used in Pharmaceutical Industry:
2,4-dimethoxy-6-(2-oxopropyl)benzoic acid is used as an analgesic and anti-inflammatory agent for the treatment of pain, swelling, and joint stiffness caused by various inflammatory conditions such as arthritis. It is prescribed for short-term use to manage these symptoms effectively.
Used in Pain Management:
2,4-dimethoxy-6-(2-oxopropyl)benzoic acid is used as a pain reliever to address acute and chronic pain conditions, including musculoskeletal pain, postoperative pain, and dental pain. Its anti-inflammatory properties also aid in reducing inflammation associated with these conditions.
Used in Topical Treatments:
2,4-dimethoxy-6-(2-oxopropyl)benzoic acid is used in the form of topical gels and creams for localized pain relief and inflammation reduction, particularly for conditions such as sprains, strains, and muscle injuries. This application allows for targeted treatment with minimal systemic side effects.
It is crucial to follow the guidance of a healthcare professional when using 2,4-dimethoxy-6-(2-oxopropyl)benzoic acid to ensure safe and effective treatment, as well as to minimize the risk of side effects and drug interactions.
Check Digit Verification of cas no
The CAS Registry Mumber 6512-31-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,5,1 and 2 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 6512-31:
(6*6)+(5*5)+(4*1)+(3*2)+(2*3)+(1*1)=78
78 % 10 = 8
So 6512-31-8 is a valid CAS Registry Number.
6512-31-8Relevant academic research and scientific papers
BIOSYNTHESIS OF CANESCIN, A METABOLITE OF ASPERGILLUS MALIGNUS : INCORPORATION OF METHIONINE, ACETATE, SUCCINATE, AND ISOCOUMARIN PRECURSORS, LABELLED WITH DEUTERIUM AND CARBON-13
Lewis, Christopher N.,Staunton, James,Sunter, David C.
, p. 747 - 754 (2007/10/02)
The biosynthesis of canescin (1), a metabolite of Aspergillus malignus, has been studied using methionine, sodium- and acetate, and sodium- and -succinate as simple precursors, and deuterium labelled isocoumarins as potential advanced precursors.Analysis of the labelled products by both n.m.r. and mass spectrometry suggests that 6,8-dihydroxy-3,7-dimethylisocoumarin (13) is the first enzyme-free intermediate produced by the polyketide synthase, and the 7-formyl-6,8-dihydroxy-3-methylisocoumarin (16) is a later intermediate on the pathway.Incorporation into canescin of (13)C together with one deuterium atom from methionine proves that the formyl group of (16) is derived from this source and that it is not oxidised to the level of a carboxylic acid in subsequent steps.The (13)C labels in the succinate units are incorporated into the γ-lactone carbons (C-11 to C-13) of canescin, but with complete loss of the neighbouring deuterium label.
